Spineart today announces that it secured a EUR 30 million investment from Gimv[1]. These proceeds will be used to reinforce the company’s sales organization and processes, for further geographical expansion in selective markets such as the US and Europe, as well as for continued development of innovative and disruptive products.
“Gimv is the partner we need to reach the next level. Its Health & Care team’s experience in accompanying fast growing companies will help to reach Spineart’s ambitious goals. Therefore, we are very pleased to have them on board and are excited to write together the next chapter in Spineart’s history,” said Jérôme Levieux and Stéphane Mugnier-Jabob, co-founders and co-CEOs of Spineart.
Gimv is an investment company with over three decades experience in private equity and venture capital, listed on Euronext Brussels. The company identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders, and currently manages around 1.8 billion EUR of investments.
Peter Byloos, Partner in Gimv’s Health & Care team, comments: “Spine surgery is an attractive global market offering plenty of room for challengers such as Spineart. Next to its broad product portfolio and recognized European brand, the company differentiates itself by a strong focus on product innovation and full R&D pipeline. We look forward to share our expertise in the field of Building Companies and International Operations with Spineart’s experienced and committed leadership team”.
More information on Gimv can be found on www.gimv.com.
[1] Joint-investment by Gimv and the Gimv Health & Care Fund